{
}
Novo Nordisk's shares plummeted over 21% following disappointing results from the Phase 3 trial of its obesity drug CagriSema, which achieved a 22.7% average weight reduction, falling short of the expected 25%. Analysts have reacted with downgrades, citing safety concerns and underperformance compared to competitors. Despite achieving primary study objectives, the market's response reflects significant investor disappointment.
Merck & Co. is shifting its focus from TIGIT and LAG-3 inhibitors to a subcutaneous version of Keytruda and a PD-1x/VEGF bispecific, while entering the obesity market with a preclinical GLP-1 receptor agonist from Hansoh Pharma for $112 million. Sanofi reported promising mid-stage results for its TL1A antibody duvakitug in inflammatory bowel disease, achieving significant remission rates, while Vertex Pharmaceuticals faced setbacks with its NaV1.8 inhibitor suzetrigine in chronic pain trials. Novo Nordisk completed a $16.5 billion acquisition of Catalent to address supply issues for semaglutide, despite ongoing shortages, while Novartis announced the closure of two MorphoSys sites, affecting 330 employees, following an $800 million write-down on pelabresib.
The global CMO in Healthcare market report provides a comprehensive analysis of market structure, growth factors, and competitive landscape, forecasting trends from 2024 to 2030. Key players include Accellent, Boehringer Ingelheim, and Catalent, with a focus on regional dynamics across North America, Europe, and Asia. The report highlights market segmentation by type and application, emphasizing the driving forces and potential restraints impacting future developments.
The Blow-Fill-Seal (BFS) Packaging Services in Healthcare market is experiencing significant growth, driven by rising demand and technological advancements. A comprehensive report analyzes market trends, competitive dynamics, and future prospects, highlighting key players like Recipharm AB and Nephron Pharmaceuticals. The study also delves into consumption patterns, pricing strategies, and market segmentation, providing valuable insights for stakeholders.
Jeff Stute, a seasoned investment banker with three decades of experience, is joining Citigroup as vice president of North American healthcare mergers, effective December. His recruitment aims to enhance Citi's healthcare M&A capabilities amid a competitive landscape, following recent promotions within the team. Stute previously held significant roles at Perella Weinberg Partners and JPMorgan Chase, advising on major pharmaceutical deals.
Citi has recruited Jeff Stute from Perella Weinberg Partners to enhance its healthcare M&A division, where he will serve as vice president starting in December. With over 30 years of experience, Stute aims to strengthen Citi's market position amid a competitive landscape, following recent promotions within the team. The healthcare M&A market has seen a 13% decline in deal volume this year, highlighting the challenges ahead.
Citigroup has promoted Sumit Khedekar to global head of healthcare, alongside Nishant Jadav as Global Head of Healthcare Services and Michael Guarino as head of healthcare services in North America. These appointments reflect the bank's strategy to enhance its investment banking presence in the healthcare sector, following notable transactions like the $16.5 billion sale of Catalent to Novo Nordisk.
The global contract development and manufacturing organization (CDMO) market, valued at USD 130.8 billion in 2018, is projected to reach USD 278.98 billion by 2026, growing at a CAGR of 10.0%. This growth is driven by rising demand for novel therapies, increasing complexity of treatments, and strategic partnerships between pharmaceutical companies and CDMOs. Key trends include market consolidation and significant investments in infrastructure, while challenges such as stringent regulations may hinder growth.
Catalent, Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
novo nordisk faces stock plunge after disappointing results for obesity drug
Danish Krone
Catalent, Inc.
Novo Nordisk A/S
Eli Lilly and Company
DNK
Florent Cespedes
Emmanuel Papadakis
Jo Walton
Peter Welford
Show more
15:35 20.12.2024
merck shifts focus to biotech and obesity as keytruda exclusivity looms
United States Dollar
Sanofi
Vertex Pharmaceuticals Inc
Merck & Co., Inc.
Catalent, Inc.
Novartis AG
Novo Nordisk A/S
USA
Show more
04:47 20.12.2024
global cmo in healthcare market analysis and future growth prospects
10:03 22.11.2024
blow fill seal packaging services in healthcare market trends and growth forecast
Catalent, Inc.
Nephron Pharmaceuticals Corporation Corporation
Robert Bosch Packaging Technology GmbH
Vertiv Holdings Co
Recipharm AB
Alice Mutum
Unither
Mr. Shah
Robert Bosch
Horizon Pharmaceuticals Inc.
Show more
11:23 12.11.2024
citi hires jeff stute to enhance healthcare mergers and acquisitions team
United States Dollar
Perella Weinberg Partners
The Goldman Sachs Group, Inc.
JPMorgan Chase & Co.
Catalent, Inc.
Citizens, Inc.
USA
Nishant Jadav
Jeff Stute
Kevin Cox
Sumit Khedekar
Torrey Browder
Show more
15:14 04.11.2024
Citi hires Jeff Stute to enhance healthcare mergers and acquisitions team
United States Dollar
Perella Weinberg Partners
The Goldman Sachs Group, Inc.
Citigroup Inc.
JPMorgan Chase & Co.
Centerview Partners
Novo Nordisk A/S
Catalent, Inc.
USA
Novo Nordisk
Jeff Stute
Sabrina Valle
Kevin Cox
Torrey Browder
Show more
15:10 04.11.2024
Citigroup promotes three bankers to enhance healthcare investment banking efforts
United States Dollar
Catalent, Inc.
Novo Nordisk A/S
Bank of America Corporation
Citigroup Inc.
Credit Suisse Anlagestiftung
The Goldman Sachs Group, Inc.
USA
Sumit Khedekar
Nishant Jadav
Michael Guarino
Show more
18:43 22.10.2024
global cdmo market projected to reach 279 billion by 2026
United States Dollar
Recipharm AB
Baxter International Inc.
Catalent, Inc.
Thermo Fisher Scientific Inc.
CHE
USA
Paragon Bio Services
Cambrex Corporation
Avista Pharma Solutions
Inc
Catalent
Recipharm AB
Show more
09:00 14.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Stock Market Updates
Supply Chain Management
Government Economic Policies
Private Equity Deals
Industry Mergers & Acquisitions
Venture Capital Investments
Fintech Startups
Energy Sector Developments
IPOs & SPACs
Funding Rounds & Investments
Decentralized Finance (DeFi) Innovations
Inflation and Monetary Impact
Economic Indicators
AI Innovations
Global Trade Policies
Countries:
Companies:
Apple Inc.
NVIDIA Corp
Ripple USD USD
The Goldman Sachs Group, Inc.
Visa Inc.
Mastercard Inc
Micron Technology, Inc.
SWIGGY LIMITED
Tesmec S.p.A.
SAP SE
Ather Energy Ltd.
GLOE Inc.
Microsoft Corporation
J.P. Morgan Fixed Income Opps A EUR Inc
S&P 500
J&T EXPRESS-W
NAURA Technology Group Co., Ltd.
Bajaj Auto Limited
OLA ELECTRIC MOBILITY LTD
Teradyne, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
Saudi Riyal
United Arab Emirates Dirham
Canadian Dollar
Indonesian Rupiah
South Korean Won
Malaysian Ringgit
Brazilian Real
Swiss Franc
New Zealand Dollar
British Pound Sterling
Qatari Riyal
Bangladeshi Taka
Kuwaiti Dinar
People: